Repression of PRMT activities sensitize human homologous recombination-proficient ovarian and breast cancer cells to PARP inhibitor treatment. (elifesciences.org)

Authors: Zhang Y … Hu X Journal: eLife Published: 2026-02-03 DOI: https://doi.org/10.7554/eLife.99225